This activation reduces the inhibitory binding between Caveolin-1 and eNOS, allowing greater eNOS activation and nitric oxide productionwith laboratory studies showing BPC-157 at 1 g/ml increases NO production 1.35-fold compared to controls
Cardiovasc Res 36:276281 Masaki I, Yonemitsu Y, Yamashita A, Sata S, Tanii M, Komori K, Nakagawa K, Hou X, Nagai Y, Hasegawa M et al (2002) Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2
HUBERMAN: Make sure that you're not taking too much of it or for too long, and keep an eye on those prolactin levels because those can be problematic if they get too high
This is where my practice at Tanglewood Foot Specialists operates differently from most foot care
I'm 84 years old and if something works for me, I'll take it